Ziopharm Oncology Company Profile (NASDAQ:ZIOP)

About Ziopharm Oncology

Ziopharm Oncology logoZIOPHARM Oncology, Inc. is a biopharmaceutical company. The Company is seeking to acquire, develop and commercialize, on its own or with partners, a portfolio of cancer therapies through synthetic immuno-oncology. Its clinical-stage product candidate, Ad-RTS-IL-12, is used with the oral activator veledimex. The Company's Ad-RTS-IL-12 + veledimex has been evaluated in two Phase II studies, the first for the treatment of metastatic melanoma, and the second for the treatment of unresectable recurrent or metastatic breast cancer. It has initiated the Phase I study for malignant glioma. The Company has completed the Phase II monotherapy studies in melanoma and breast cancer using Ad-RTS-IL-12 + veledimex. It has initiated a Phase Ib/II study of Ad-RTS-hIL-12 + veledimex following chemotherapy for the treatment of patients with locally metastatic breast cancer. Its initial drug candidate being developed using the synthetic immuno-oncology platform is Ad-RTS-IL-12 + veledimex.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: ZIOP
  • CUSIP: 98973P10
Key Metrics:
  • Previous Close: $5.18
  • 50 Day Moving Average: $5.24
  • 200 Day Moving Average: $6.78
  • 52-Week Range: $4.45 - $14.93
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -11.02
  • P/E Growth: 0.00
  • Market Cap: $675.97M
  • Outstanding Shares: 130,496,000
  • Beta: 1.51
Additional Links:
Companies Related to Ziopharm Oncology:

Analyst Ratings

Consensus Ratings for Ziopharm Oncology (NASDAQ:ZIOP) (?)
Ratings Breakdown: 4 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.20)
Consensus Price Target: $10.83 (109.14% upside)

Analysts' Ratings History for Ziopharm Oncology (NASDAQ:ZIOP)
Show:
DateFirmActionRatingPrice TargetDetails
8/15/2016Griffin SecuritiesReiterated RatingBuy$21.00View Rating Details
8/10/2016Wells Fargo & Co.UpgradeUnderperform -> Market PerformView Rating Details
7/18/2016MizuhoReiterated RatingNeutral$7.00 -> $5.00View Rating Details
6/2/2016Raymond James Financial Inc.Initiated CoverageMarket PerformView Rating Details
1/15/2016JPMorgan Chase & Co.Reiterated RatingHoldView Rating Details
6/22/2015BMO Capital MarketsDowngradeOutperform -> Market Perform$15.00 -> $10.00View Rating Details
5/13/2015GuggenheimInitiated CoverageNeutralView Rating Details
(Data available from 8/31/2014 forward)

Earnings

Earnings History for Ziopharm Oncology (NASDAQ:ZIOP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/31/2016        
8/9/2016Q216($0.11)($1.01)$1.52 million$1.70 millionViewN/AView Earnings Details
5/10/2016Q1($0.08)($0.09)$1.89 million$1.97 millionViewN/AView Earnings Details
2/24/2016Q4($0.07)($0.07)ViewN/AView Earnings Details
11/2/2015Q315($0.13)($0.14)$1.19 million$1.90 millionViewN/AView Earnings Details
8/10/2015Q2($0.22)($0.11)ViewN/AView Earnings Details
5/7/2015($0.13)($0.10)$0.20 million$0.30 millionViewN/AView Earnings Details
2/26/2015Q414($0.14)($0.09)$420.00 million$0.34 millionViewN/AView Earnings Details
10/30/2014Q314($0.12)($0.06)$3.43 millionViewN/AView Earnings Details
8/7/2014Q214($0.17)($0.06)$7.50 million$0.20 millionViewN/AView Earnings Details
5/8/2014Q114($0.10)($0.10)$0.20 million$0.20 millionViewN/AView Earnings Details
3/3/2014Q413($0.15)($0.09)$0.20 million$0.20 millionViewN/AView Earnings Details
10/22/2013Q313($0.17)($0.20)$0.20 millionViewN/AView Earnings Details
8/8/2013Q2 2013($0.24)($0.22)$0.20 million$0.20 millionViewN/AView Earnings Details
3/18/2013Q4 2012($0.29)($0.48)$0.17 million$0.20 millionViewN/AView Earnings Details
11/8/2012Q312($0.28)($0.28)$0.20 million$0.20 millionViewN/AView Earnings Details
8/2/2012($0.23)($0.29)ViewN/AView Earnings Details
5/3/2012($0.22)($0.25)ViewN/AView Earnings Details
2/29/2012($0.23)($0.24)ViewN/AView Earnings Details
11/3/2011($0.28)($0.01)ViewN/AView Earnings Details
8/1/2011($0.23)($0.16)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Ziopharm Oncology (NASDAQ:ZIOP)
Current Year EPS Consensus Estimate: $-1.34 EPS
Next Year EPS Consensus Estimate: $-0.47 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.07)($0.07)($0.07)
Q2 20161($0.12)($0.12)($0.12)
Q3 20161($0.12)($0.12)($0.12)
Q4 20161($0.11)($0.11)($0.11)
Q2 20171($0.12)($0.12)($0.12)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Ziopharm Oncology (NASDAQ:ZIOP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Ziopharm Oncology (NASDAQ:ZIOP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/4/2015Murray BrennanDirectorSell40,000$9.70$388,000.00View SEC Filing  
2/9/2015Randal J KirkDirectorBuy1,440,000$8.75$12,600,000.00View SEC Filing  
10/29/2013Randal J KirkDirectorBuy2,857,143$3.50$10,000,000.50View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Ziopharm Oncology (NASDAQ:ZIOP)
DateHeadline
News IconNotable Stock's Buzzers: ZIOPHARM Oncology Inc.(NASDAQ:ZIOP ... - NYSE Journal (press release) (NASDAQ:ZIOP)
stockznews.com - August 27 at 5:22 AM
benzinga.com logoMid-Afternoon Market Update: Guess? Jumps On Earnings Beat; Signet Jewelers Shares Tumble - Benzinga (NASDAQ:ZIOP)
www.benzinga.com - August 25 at 8:39 PM
News IconBiotech Stocks To Put On Your Watch List: ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP), ImmunoCellular Therapeutics ... - The Voice Registrar (NASDAQ:ZIOP)
voiceregistrar.com - August 25 at 5:22 AM
News IconAnalyst's keeping an Eye on: ZIOPHARM Oncology Inc (NASDAQ ... - Newburg Press (NASDAQ:ZIOP)
newburghpress.com - August 23 at 8:32 PM
News IconZIOPHARM Oncology, Inc.'s (ZIOP): Investor's Alert - Hot Stocks Point (NASDAQ:ZIOP)
www.hotstockspoint.com - August 23 at 8:32 PM
News IconIntraday Active Biotech Stocks News: ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP), Vertex Pharmaceuticals Incorporated ... - The Voice Registrar (NASDAQ:ZIOP)
voiceregistrar.com - August 23 at 8:32 PM
thestreet.com logoZIOP April 2017 Options Begin Trading (NASDAQ:ZIOP)
www.thestreet.com - August 22 at 8:22 PM
finance.yahoo.com logoZIOPHARM ONCOLOGY INC Financials (NASDAQ:ZIOP)
finance.yahoo.com - August 18 at 8:37 PM
investornewswire.com logoCan ZIOPHARM Oncology Inc (NASDAQ:ZIOP) Keep Up With Analyst Expectations? - Investor Newswire (NASDAQ:ZIOP)
www.investornewswire.com - August 18 at 11:36 AM
marketnewsvideo.com logoNotable Wednesday Option Activity: FDX, ZIOP, BAH (NASDAQ:ZIOP)
www.marketnewsvideo.com - August 17 at 8:44 PM
News IconZIOPHARM Oncology Inc. (NASDAQ:ZIOP): It’s All About Timing The Buy Action To Make Quick Money (NASDAQ:ZIOP)
www.marketnewscall.com - August 17 at 11:24 AM
News IconAnalysts Valuations For Two Stocks: ZIOPHARM Oncology Inc. (ZIOP), Bed Bath & Beyond Inc. (BBBY) - The Voice Registrar (NASDAQ:ZIOP)
voiceregistrar.com - August 16 at 11:47 AM
capitalcube.com logoZIOPHARM Oncology, Inc. breached its 50 day moving average in a Bullish Manner : ZIOP-US : August 16, 2016 (NASDAQ:ZIOP)
www.capitalcube.com - August 16 at 11:47 AM
News IconZIOPHARM Oncology Inc. (NASDAQ:ZIOP): That’s How We Bought At $5.09 And Now Up 15% Already (NASDAQ:ZIOP)
www.marketnewscall.com - August 15 at 8:44 PM
capitalcube.com logoETF’s with exposure to ZIOPHARM Oncology, Inc. : August 15, 2016 (NASDAQ:ZIOP)
www.capitalcube.com - August 15 at 8:44 PM
News IconBiotech news that matter for investors: ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP), Sangamo Biosciences Inc ... - The Voice Registrar (NASDAQ:ZIOP)
voiceregistrar.com - August 12 at 8:35 PM
capitalcube.com logoZIOPHARM Oncology, Inc. :ZIOP-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:ZIOP)
www.capitalcube.com - August 12 at 8:35 PM
News IconBiotech news that matter for investors: ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP), ImmunoCellular Therapeutics, Ltd ... - The Voice Registrar (NASDAQ:ZIOP)
voiceregistrar.com - August 11 at 9:04 PM
finance.yahoo.com logoZIOPHARM upgraded by Wells Fargo (NASDAQ:ZIOP)
finance.yahoo.com - August 10 at 9:11 PM
thestreet.com logoZiopharm Oncology (ZIOP) Stock Advances After Q2 Results, Upgrade (NASDAQ:ZIOP)
www.thestreet.com - August 10 at 9:11 PM
globenewswire.com logoZIOPHARM Reports Second-Quarter 2016 Financial Results and Provides Update on Recent Activities (NASDAQ:ZIOP)
globenewswire.com - August 9 at 8:46 PM
reuters.com logoBRIEF-Ziopharm Q2 loss per share $1.01 (NASDAQ:ZIOP)
www.reuters.com - August 9 at 8:45 PM
twst.com logoZIOPHARM Oncology Inc.: ZIOPHARM Reports Second-Quarter 2016 Financial Results and Provides Update on Recent Activities (NASDAQ:ZIOP)
www.twst.com - August 9 at 8:45 PM
sg.finance.yahoo.com logoZiopharm reports 2Q loss (NASDAQ:ZIOP)
sg.finance.yahoo.com - August 9 at 8:45 PM
streetinsider.com logoZiopharm (ZIOP) Announces Positive Sleeping Beauty System Update in CAR T-Cells; Strong Autologous OS Noted (NASDAQ:ZIOP)
www.streetinsider.com - August 6 at 10:58 AM
News IconBiotech Stocks Worth a Closer Look: ZIOPHARM Oncology ... - The Voice Registrar (NASDAQ:ZIOP)
voiceregistrar.com - August 5 at 11:32 AM
News IconHC Stocks Summary: Skyline Medical Inc (NASDAQ:SKLN), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) - share market updates (press release) (NASDAQ:ZIOP)
sharemarketupdates.com - August 5 at 11:32 AM
fortune.com logoStock Analyst Opinions On Watch List: ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), Tronox Ltd (NYSE:TROX) - Review Fortune (NASDAQ:ZIOP)
reviewfortune.com - August 5 at 11:32 AM
News IconIntraday Active Biotech Stocks News: Celldex Therapeutics, Inc. (NASDAQ:CLDX), ZIOPHARM Oncology, Inc ... - The Voice Registrar (NASDAQ:ZIOP)
voiceregistrar.com - August 4 at 8:54 PM
finance.yahoo.com logo7:04 am ZIOPHARM announces the publication of data highlighting the benefits of using the non-viral Sleeping Beauty system to genetically modify T-cells to express a CAR for use against leukemias and lymphomas (NASDAQ:ZIOP)
finance.yahoo.com - August 4 at 11:43 AM
publicnow.com logoFirst-In-Human Trials using Non-Viral Sleeping Beauty System to Express CD19-Specific CAR in T cells Published in Journal of Clinical Investigation (NASDAQ:ZIOP)
www.publicnow.com - August 4 at 11:43 AM
sbwire.com logo"Colon Cancer - Pipeline Review, H1 2016" Is Now Available at Fast Market Research (NASDAQ:ZIOP)
www.sbwire.com - August 3 at 11:46 AM
News IconInvestor News: ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) under Investigation over potential Violations of Securities Laws (NASDAQ:ZIOP)
www.groundreport.com - August 2 at 8:50 PM
finance.yahoo.com logoZIOPHARM to Hold Second Quarter 2016 Financial Results Conference Call and Webcast on Tuesday, August 9, 2016 (NASDAQ:ZIOP)
finance.yahoo.com - August 2 at 8:50 PM
News IconIntraday Active Biotech Stocks News: Tesaro, Inc. (NASDAQ:TSRO ... - The Voice Registrar (NASDAQ:ZIOP)
voiceregistrar.com - August 1 at 8:10 PM
News IconAnalyst's Report Preview: ZIOPHARM Oncology Inc. (NASDAQ:ZIOP ... - The Voice Registrar (NASDAQ:ZIOP)
voiceregistrar.com - August 1 at 8:10 PM
News Icon2 Biotech Stocks News And Price Trends: ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP), Progenics Pharmaceuticals, Inc ... - The Voice Registrar (NASDAQ:ZIOP)
voiceregistrar.com - July 29 at 11:32 AM
News IconEarnings Analysis to see: ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP), IAC/InterActiveCorp (NASDAQ:IAC) - News Oracle (NASDAQ:ZIOP)
www.newsoracle.com - July 29 at 11:32 AM
News IconBiotech news that matter for investors: Nektar Therapeutics ... - The Voice Registrar (NASDAQ:ZIOP)
voiceregistrar.com - July 28 at 8:56 PM
streetupdates.com logoNotable Stocks within Analysts Radar: Johnson & Johnson (NYSE ... - Street Updates (NASDAQ:ZIOP)
www.streetupdates.com - July 28 at 8:56 PM
fortune.com logoNotable Research Reports: Jabil Circuit, Inc. (NYSE:JBL), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) - Review Fortune (NASDAQ:ZIOP)
reviewfortune.com - July 28 at 8:56 PM
sbwire.com logoInvestigation for Investors in Shares of ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) over Potential Violations of Securities Laws (NASDAQ:ZIOP)
www.sbwire.com - July 26 at 12:01 PM
kcregister.com logoWells Fargo & Company (NYSE:WFC) went up 0.04%: Intrexon Corporation (NYSE:XON), ZIOPHARM Oncology, Inc ... - KC Register (NASDAQ:ZIOP)
www.kcregister.com - July 25 at 8:38 PM
streetupdates.com logoAnalysts Reviewing Stocks Update: Valeant Pharmaceuticals International, Inc. (NYSE:VRX) , ZIOPHARM Oncology Inc ... - Street Updates (NASDAQ:ZIOP)
www.streetupdates.com - July 22 at 8:13 PM
News Icon2 Biotech Stocks News And Price Trends: ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP), Opko Health, Inc. (NASDAQ:OPK) - The Voice Registrar (NASDAQ:ZIOP)
voiceregistrar.com - July 22 at 8:13 PM
equities.com logoZIOPHARM Oncology Inc (ZIOP) Drops 8.02% on July 19 - Equities.com (NASDAQ:ZIOP)
www.equities.com - July 22 at 8:13 PM
fortune.com logoZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) Earns Consensus Hold Rating - Review Fortune (NASDAQ:ZIOP)
reviewfortune.com - July 22 at 8:13 PM
News IconHC Stocks Alerts: Skyline Medical Inc (NASDAQ:SKLN), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) - share market updates (press release) (NASDAQ:ZIOP)
sharemarketupdates.com - July 22 at 8:13 PM
News IconBiotech industry kills another cancer patient in experimental drug study (NASDAQ:ZIOP)
www.naturalnews.com - July 22 at 11:22 AM
4-traders.com logoZIOPHARM Oncology : Provides Update Regarding Phase I Study of Gene Therapy Candidate Ad-RTS-hIL-12 in Brain Cancer (NASDAQ:ZIOP)
www.4-traders.com - July 21 at 8:47 PM

Social

Ziopharm Oncology (NASDAQ:ZIOP) Chart for Wednesday, August, 31, 2016


Last Updated on 8/31/2016 by MarketBeat.com Staff